Please login to the form below

Not currently logged in
Email:
Password:

Dr Susanne Fiedler takes over as CEO of MSD Germany

Hanspeter Quodt steps down after seven years in the post

MSD Dr Susanne FiedlerMSD Germany has appointed Dr Susanne Fiedler as CEO to take over from Hanspeter Quodt, who steps after seven years in the post.

Dr Fielder first joined the German operations of Merck & Co in 1997, when she took up a role in market research.

She then moved to market, initially as a product manager and later as a marketing manager and then a business unit head with responsibility for a number of MSD products.

Since then Dr Fielder has served in the US, where MSD operates at Merck & Co, as global brand leader for the diabetes treatments Januvia and Janumet, before taking up a Sydney-based role as managing director of MSD Australia and New Zealand.

She will officially take on her new role on 1 February, when Quodt moves to a new European level position.

27th January 2016

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

The immunotherapy knowledge gap: keeping the patient at the heart of cancer treatment
Advances in cancer treatment are frequent, but how much do we actually understand about these new treatments?...
Value is in the eye of the customer. Co-creation is a bridge to value.
We conducted 16 hours of qualitative interviews with HCPs and Senior Pharma industry leaders in the UK, supported with in-depth industry scanning. Our interviews reveal important insights about the tensions...
Partnering with Patients and Caregivers in Clinical Research
...